Press Release

Vancomycin-Resistant Staphylococcus Aureus Drugs Market Growth, Trends, Industry Analysis, Share, Forecast till 2026 | Fortune Business Insights

According to the Department of Health, around 20% of the population worldwide is inhabited with Staphylococcus aureus. This can fuel demand for vancomycin-resistant staphylococcus aureus drugs, thus driving the global vancomycin-resistant staphylococcus aureus drugs market. The information is shared by Fortune Business Insights in a report, titled “Vancomycin-Resistant Staphylococcus aureus (VRSA) Drugs Market Size, Share and Global Trend By Product (Linezolid, Tigecycline, Daptomycin, Telavancin, Ceftaroline, Quinupristin, Dalfopristin, Others), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies Retail Pharmacies, Online Pharmacies, Others) and Geography Forecast Till 2026.”

some of the key players in the global Vancomycin-Resistant Staphylococcus Aureus Drugs Market:

  • GlaxoSmithKline
  • AstraZeneca Plc
  • Cubist Pharmaceutical
  • Forest Laboratories
  • Debiopharm International
  • iNtRON Biotechnology
  • Crystal Genomics
  • Wockhardt Limited
  • Destiny Pharma Ltd
  • Therapeutic Systems Research Laboratories Inc.

Get Sample PDF Brochure:

Key Segmentation of Vancomycin-Resistant Staphylococcus Aureus Drugs Market:

By Product

  • Linezolid
  • Tigecycline
  • Daptomycin
  • Telavancin
  • Ceftaroline
  • Quinupristin
  • Dalfopristin
  • Others

By Route of Administration

  • Oral
  • Parenteral

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

More Trending Topics from Fortune Business Insights:

Multiple Myeloma Market Share

Multiple Myeloma Market Size

Opioid Use Disorder (OUD) Market Size

Opioid Use Disorder (OUD) Market Share

Opioid Use Disorder (OUD) Market Size

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *